Supernus Pharmaceuticals
SUPN
#4338
Rank
NZ$3.36 B
Marketcap
$60.86
Share price
-1.14%
Change (1 day)
34.61%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: NZ$3.36 Billion

As of November 2024 Supernus Pharmaceuticals has a market cap of NZ$3.36 Billion. This makes Supernus Pharmaceuticals the world's 4338th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$3.36 B34.43%
2023NZ$2.50 B-17.68%
2022NZ$3.03 B33.77%
2021NZ$2.27 B23.15%
2020NZ$1.84 B-0.36%
2019NZ$1.85 B-28.59%
2018NZ$2.59 B-9.92%
2017NZ$2.87 B59.28%
2016NZ$1.80 B87.65%
2015NZ$0.96 B111.39%
2014NZ$0.45 B24.09%
2013NZ$0.36 B37.46%
2012NZ$0.26 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Supernus Pharmaceuticals was reported to be:

NZ$3.39 Billion
by Nasdaq info icon info icon
NZ$3.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.55 B-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.92 B 730.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.214 T 36,045.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$201.55 B 5,897.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$346.26 B 10,202.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$639.41 B 18,925.25%๐Ÿ‡บ๐Ÿ‡ธ USA